Author Archives: Scalper1

Active Power: An Analyst Catalyst Candidate?

ACPW reported an impressive Q2 which put the finishing touches on a further impressive 1H. The analyst community has taken notice. With changing estimate trend lines is ACPW an Analyst Catalyst candidate? Seeking Alpha readers who follow my writings understand just how lucrative identifying this can be. It looks like analysts are beginning to see a good story and a story in which they are collectively getting more and more confident in when it comes to Active Power (NASDAQ: ACPW ). After the company’s Q2/15 reporting confirmed what is shaping up to be an inflection point for operations analysts have come to modeling Active Power more bullish than prior and, importantly, more bullish in trend than prior. This matters in a big, big way for getting some volume into the name and for getting some valuation multiple expansion. I detailed the Active Power quarter reported in an initiation note in which I concluded the same as apparently what is now becoming a very consensus analyst opinion -Active Power is finally on its way to healthier income statement performances. Still, to see analysts turn estimate trends positive is encouraging and could, with a quarter or two of further execution, turn into the phenomenon I’ve called the Analyst Catalyst. I’ve detailed this before for Seeking Alpha readers in other names near inflection points of several varieties (growth rates, cash flow positive, EBITDA positive, etc.). It’s been a long, long time since Active Power was the recipient of such faith from the markets and that is reflected in its share price. A change would be welcomed by shareholders and is something that shareholders should pay close attention to. Active Power is currently modeled for steady increases to revenue, EBITDA, and fully diluted EPS to end full year 2015. Through 1H/15 the company remains well on pace to hit these marks. These would be higher highs put in for the noted metrics after the company bottomed in each category in full year 2014. Full year 2014 marked Active Power’s third consecutive year of posting lower lows for the line items – something that drove its stock price lower, investor sentiment to all-time lows, and analyst faith to a point of non-existence. Obviously the modeling change to growth in these categories for full year 2015 and for full year 2016 speaks to the turnaround at the company in progress: You can see in the table above that Active Power is expected to achieve the all-important EBITDA breakeven at full year 2015 reporting with the company going on to report its first EBITDA positive year in four years at full year 2016 reporting. That will be a huge milestone for the company and one that I think will open the name up to significant investment from institutions and other asset managers that can’t or choose not to invest in non-EBITDA positive names. This is more common than most understand. Also, it’s excellent to see that Active Power is modeled to reach near breakeven for EPS in full year 2016 reporting. Again though, maybe the best part of all this is that Active Power has now established positive estimate trends across these categories. In beating estimates, Active Power has essentially validated the reporting analysts’ models – which makes them look smart, which they like. As a natural consequence of both, analysts have had to positively revise estimates at each quarter reported based on the previous beat. I believe these positive revisions, which take place early to mid-quarter, help propel volume and upward share price movement between quarterly reporting. This cumulative effect of analysts powering shares higher at early or mid-quarter AND company quarterly reporting powering shares higher works to create a constant cycle of volume and higher pricing. In general I refer to this as the Analyst Catalyst. You can see in the charts below Active Power might be on the brink of such a bullish cycle: (click to enlarge) (click to enlarge) (click to enlarge) (click to enlarge) I believe that we should see a continued Analyst Catalyst take shape at Active Power as the company continues to impress at quarterly reporting. Active Power is showing excellent trend lines for income statement line items and for key metrics reported as a result of its maturing sales team (which the cumulative effect of this is hard to model) and its growing more well-known value prop. Both should make sure that Active Power continues in its turnaround success and in reshaping its total income statement. I’ll provide updates as I see estimates positively or negatively revise. Good luck everybody. Editor’s Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

401(k) Fund Spotlight: AllianzGI NFJ Small-Cap Value Fund

Summary PCVAX’s performance is hampered by its large size. PCVAX has consistently lagged the comparable Russell 2000 Value Index. An examination of the last 2 recessionary periods reveals that PCVAX tends to outperform broader small cap indexes during bear market periods. I select funds on behalf of my investment advisory clients in many different defined contribution plans, namely 401(k)s and 403(b)s. I have looked at a lot of different funds over the years. 401(k) Fund Spotlight is an article series that focuses on one particular fund at a time that is widely offered to Americans in their 401(k) plans. 401(k)s are now the foundational retirement savings vehicle for many Americans. They should be maximized to the fullest extent. A detailed understanding of fund options is a worthwhile endeavor. To get the most out of this article it is helpful to understand my approach to investing in 401(k)s . I strive to write these articles for the benefit of the novice and professional. Please comment if you have a question. I always try to give substantive responses. The AllianzGI NFJ Small-Cap Value Fund The AllianzGI NFJ Small-Cap Value Fund has the following share classes: The net expense ratios for the share classes range from a low of .73% (R-6 shares) to a high of 1.93% (C shares). If the fund is in your 401(k), it is most likely in the form of the A shares (load waived), which have a net expense ratio of 1.18%. For the purposes of this article, I will assume the A shares are the available option and evaluate the fund based on the 1.18% expense ratio. I will use the ticker PCVAX to represent the fund name throughout the article. Fund Size Has Implications PCVAX invests in small cap companies that its managers believe are undervalued, with an emphasis on those paying dividends. The fund focuses on the universe of small cap companies with total market caps ranging from $100 million to $3.5 billion. With a little over $6 billion of total assets, the fund is one of the largest in its category. The average market cap of its 135 holdings is $2.7 billion. This has several important implications. First, the fund has to hold a lot of different stocks in order to have most of its assets invested. Otherwise, if it were to have a more concentrated portfolio (i.e., fewer stocks), it would have substantial ownership interests in these few companies. For example, to invest $6 billion in 50 companies would mean that, on average, a fund would have a $120 million stake in each company. This would mean a stake of 5% to 20% in many of the companies. This would give the investment company a lot more control-and responsibility-as it relates to those companies. My view is that there is nothing wrong with a concentrated portfolio. Indeed, I prefer it, because it would show me they know the companies so well that they are willing to make serious commitments. Sadly, most of the funds in the mutual fund industry have devolved into quasi-index funds with higher expense ratios. The industry’s entrepreneurial investment ambition died off a long time ago and it has been replaced with herd-like complacency. Second, because of this first implication, the fund has to hold a lot more stocks. The more stocks the fund owns, the closer it gets to mirroring the index. It is hard for a large, small cap fund to not be an index hugger. Third, again because of the first implication, it is very difficult for the overall fund to generate enhanced returns from investing in smaller, more unknown small caps that generate exceptional returns. The stocks are just too small to make a major difference to the fund’s overall performance. Performance There are several ways to evaluate the performance of PCVAX. Let us start by taking a look at its comparable index, the Russell 2000 Value Index, which focuses on 2,000 small capitalization (“cap”) stocks with a value orientation. In the following two charts I use the iShares Russell 2000 Value ETF (NYSEARCA: IWN ) as a proxy for the index: PCVAX Total Return Price data by YCharts PCVAX Total Return Price data by YCharts PCVAX lagged the index by more than 5% over the last 12 months and by 11.8% over the last 5 years. Most 401(k) plan participants usually do not have more than a handful of small cap focused funds to choose from (and sometimes just one or even none). If your plan has PCVAX it might also have a general small cap index fund, such as a Russell 2000 index fund, as another option. The following chart shows how the fund has fared against the iShares Russell 2000 ETF (NYSEARCA: IWM ), a proxy for the Russell 2000 index, over the last 5 years. PCVAX Total Return Price data by YCharts The Russell 2000 index has substantially outpaced PCVAX over the last 5 years. However, before you click over to your 401(k) to make an exchange. Consider the following chart: PCVAX Total Return Price data by YCharts PCVAX substantially outpaced the Russell 2000 index (using IWM proxy) during the 2007 to 2009 period that was marred by the global financial crisis and a deep recession. The value nature of PCVAX and its higher dividend yield (2.6% vs 1.7% for the Russell 2000) means it tends to outperform during periods of weaker overall stock market performance. To take this further, let’s also look at the performance of the two during the previous recessionary, bear market period of 2000 to 2002. The following chart is telling: PCVAX Total Return Price data by YCharts The performance of PCVAX utterly destroyed that of the broader Russell 2000 Index during the 2000 to 2002 time period. The fund’s investment objective also caused it to avoid many of the high flying, and wildly overvalued, small cap technology stocks on the NASDAQ. Not only did it outperform, but the fund kept cruising along in a bullish trend despite the collapsing of the technology bubble. Clearly, the value nature of the fund has some merits during recessionary, bear market periods. Conclusion PCVAX does not have any individual holdings that make up more than 2% of the fund. The performance of the fund will largely mirror that of its comparable index, the Russell 2000 Value index. Given a choice only between the two, investors may want to choose the latter, which has also outperformed PCVAX over the last 1 and 5-year periods. The lower expenses of the index also provide a constant tailwind for better performance. My stock market forecast calls for the broader U.S. market to continue to move sideways over the next two years before finally dipping lower (e.g., -5% to -15%) in the third year. Consequently, this may be a setup for a period when PCVAX, and perhaps small cap value in general, once again outperforms the broader small cap index. Investing Disclosure 401(k) Spotlight articles focus on the specific attributes of mutual funds that are widely available to American’s within employer provided defined contribution plans. Fund recommendations are general in nature and not geared towards any specific reader. Fund positioning should be considered as part of a comprehensive asset allocation strategy, based upon the financial situation, investment objectives, and particular needs of the investor. Readers are encouraged to obtain experienced, professional advice. Important Regulatory Disclosures I am a Registered Investment Advisor in the State of Pennsylvania. I screen electronic communications from prospective clients in other states to ensure that I do not communicate directly with any prospect in another state where I have not met the registration requirements or do not have an applicable exemption. Positive comments made regarding this article should not be construed by readers to be an endorsement of my abilities to act as an investment adviser. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The Importance Of Your Time Horizon

I ran across two interesting articles today: Both articles are exercises in understanding the time horizon over which you invest. If you are older, you may not have the time to recover from market shortfalls, so advice to buy dips may sound hollow when you are nearer to drawing on your assets. Thus the idea that volatility, presumably negative, doesn’t hurt unless you sell. Some people don’t have much choice in the matter. They have retired, and they have a lump sum of money that they are managing for long-term income. No more money is going in, money is only going out. What can you do? You have to plan before volatility strikes. My equity only clients had 14% cash before the recent volatility hit. Over the past week I opportunistically brought that down to 10% in names that I would like to own even if the “crisis” deepened. That flexibility was built into my management. (If the market recovers enough, I will rebuild the buffer. Around 1300 on the S&P, I would put all cash to work, and move to the alternative portfolio management strategy where I sell the most marginal ideas one at a time to raise cash and reinvest into the best ideas.) If an older investor would be hurt by a drawdown in the stock market, he needs to invest less in stocks now, even if that means having a lower income on average over the longer-term. With a higher level of bonds in the portfolio, he could more than proportionately draw down on bonds during a crisis, which would rebalance his portfolio. If and when the stock market recovered, for a time, he could draw on has stock positions more than proportionately then. That also would rebalance the portfolio. Again, plans like that need to be made in advance. If you have no plans for defense, you will lose most wars. One more note: often when we talk about time horizon, it sounds like we are talking about a single future point in time. When the time for converting assets to cash is far distant, using a single point may be a decent approximation. When the time for converting assets to cash is near, it must be viewed as a stream of payments, and whatever scenario testing, (quasi) Monte Carlo simulations, and sensitivity analyses are done must reflect that. Many different scenarios may have the same average rate of return, but the ones with early losses and late gains are pure poison to the person trying to manage a lump sum in retirement. The same would apply to an early spike in inflation rates followed by deflation. The time to plan is now for all contingencies, and please realize that this is an art and not a science, so if someone comes to you with glitzy simulation analyses, ask them to run the following scenarios: run every 30-year period back as far as the data goes. If it doesn’t include the Great Depression, it is not realistic enough. Run them forwards, backwards, upside-down forwards, and upside-down backwards. (For the upside-down scenarios normalize the return levels to the right side up levels.) The idea here is to use real volatility levels in the analyses, because reality is almost always more volatile than models using normal distributions. History is meaner, much meaner than models, and will likely be meaner in the future… we just don’t know how it will be meaner. You will then be surprised at how much caution the models will indicate, and hopefully those who can will save more, run safer asset allocations, and plan to withdraw less over time. Reality is a lot more stingy than the models of most financial Dr. Feelgoods out there. One more note: and I know how to model this, but most won’t – in the Great Depression, the returns after 1931 weren’t bad. Trouble is, few were able to take advantage of them because they had already drawn down on their investments. The many bankruptcies meant there was a smaller market available to invest in, so the dollar-weighted returns in the Great Depression were lower than the buy-and-hold returns. They had to be lower, because many people could not hold their investments for the eventual recovery. Part of that was margin loans, part of it was liquidating assets to help tide over unemployment. It would be wonky, but simulation models would have to have an uptick in need for withdrawals at the very time that markets are low. That’s not all that much different than some had to do in the recent financial crisis. Now, who is willing to throw *that* into financial planning models? The simple answer is to be more conservative. Expect less from your investments, and maybe you will get positive surprises. Better that than being negatively surprised when older, when flexibility is limited. Disclosure: None